The protective effect of parthenolide in an in vitro model of Parkinson’s disease through its regulation of nuclear factor-kappa B and oxidative stress-Reference-Cited by-同舟云学术

The protective effect of parthenolide in an in vitro model of Parkinson’s disease through its regulation of nuclear factor-kappa B and oxidative stress

Published:2024-07-17 Issue:1 Volume:51 Page:
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Shariat Razavi Seyed Ali,Vafaei Farzane,Ebrahimi Seyyed Moein,Abbasinezhad-Moud Farzaneh,Shahini Ali,Qoorchi Moheb Seraj Farid,Alavi Mohaddeseh Sadat,Fadavieslam Arghavan,Ferns Gordon A.,Bahrami Afsane

Funder

Mashhad University of M

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11033-024-09779-w.pdf

Reference56 articles.

1. Hattori N, Funayama M, Imai Y, Hatano T (2024) Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers. J Neural Transm. https://doi.org/10.1007/s00702-024-02747-5

2. Hamidpour SK, Amiri M, Ketabforoush AHME, Saeedi S, Angaji A, Tavakol S (2024) Unraveling dysregulated cell signaling pathways, genetic and epigenetic mysteries of Parkinson’s disease. Mol Neurobiol. https://doi.org/10.1007/s12035-024-04128-1

3. Bhusal CK, Uti DE, Mukherjee D, Alqahtani T, Alqahtani S, Bhattacharya A et al (2023) Unveiling nature’s potential: promising natural compounds in Parkinson’s disease management. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2023.105799

4. Mythri RB, Bharath MM (2012) Curcumin: a potential neuroprotective agent in Parkinson’s disease. Curr Pharm Des 18(1):91–99

5. Ikeda Y, Tsuji S, Satoh A, Ishikura M, Shirasawa T, Shimizu T (2008) Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 107(6):1730–1740